Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

KF-20444: Kyowa Hakko's novel antirheumatic agent

Aug. 23, 1996

SR-3775: Promising candidate for cytomegalovirus disease treatment

Aug. 23, 1996

Antidiabetic efficacy of ABB demonstrated in rats

Aug. 16, 1996

Anticoagulant hirudin analogue NF-22 designated developmental candidate

Aug. 16, 1996

Calpain inhibitor PD-150606 shows neuroprotective effects

Aug. 16, 1996

BTS-73947: new D1/D5 antagonist from Knoll

Aug. 16, 1996

Roche profiles pharmacokinetics, pharmacodynamics of new benzodiazepine

Aug. 16, 1996

first clinical study results reported for Ro-48-6791

Aug. 16, 1996

LY-23728, 5-HT2B antagonist reported by Lilly

Aug. 16, 1996

Histamine H3 agonist increases slow-wave sleep in rats

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...